摘要
目的 观察司氟沙星治疗非淋菌性尿道 宫颈炎的有效性和安全性。 方法 12 8例病人随机分为观察组和对照组 ,观察组 82例口服司氟沙星 10 0mg ,每日 2次 ,疗程 10d ,对照组 46例口服罗红霉素 15 0mg ,每日 2次 ,疗程10d。 结果 观察组痊愈率为 80 5 % (66 82 ) ,总有效率为 91 5 % (75 82 )。对照组痊愈率为 60 9% (2 8 46) ,总有效率为 67 4% (3 1 46) ,差异有显著性意义 (P <0 .0 1) 结论 司氟沙星治疗非淋菌性尿道 宫颈炎是安全有效的。
Objective To observe the clinical therapeutic efficacy and safety sparfloxacin for treatment of nongonococcal urethritis(cervicitis). Methods 128 patients with infective disease of urinary and genital systm were divided into 2 groups. The sparfloxacin group 82 cases were treated with sparfloxacin 100mg ,po ,bid,for a course of is 10d. The 46 cases in roxithromycin group were treated with roxithromycin 150mg,po,bid,for a course of is 10d. Results The cure rate were 80.5%(66/82)in sparfloxacin group and 60.9%(28/46)in roxithromycin group,the efficacy rate were 91.5%(75/82)in sparfloxacin group and 67.4%(31/46),respectively,a significant difference existed between the two groups(P<0.01). Conclusion It is indicated that sparfloxacin is well-tolerated and effective for the treatment of nongonococcal urethritis and cervicitis.
出处
《中国热带医学》
CAS
2003年第6期783-784,共2页
China Tropical Medicine
